🐢
|
Annual incidence of inflammatory joint diseases in a population based study in southern Sweden
M. Söderlin,
Olle Börjesson,
Hannu Kautiainen,
T. Skogh,
M. Leirisalo-Repo
|
7 |
2002 |
7 🐢
|
🐢
|
Progression of cervical spine changes in patients with early rheumatoid arthritis.
L. Paimela,
Leena Laasonen,
E. Kankaanpää,
M. Leirisalo-Repo
|
6 |
1997 |
6 🐢
|
🐢
|
Chlamydia pneumoniae as a triggering infection in reactive arthritis.
T. Hannu,
M. Puolakkainen,
M. Leirisalo-Repo
|
6 |
1999 |
6 🐢
|
🐢
|
Effectiveness of different cryotherapies on pain and disease activity in active rheumatoid arthritis. A randomised single blinded controlled trial.
H. Hirvonen,
Hannu J. Kautiainen,
M. Leirisalo-Repo
|
6 |
2006 |
6 🐢
|
🐜
|
Finnish case–control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis
14 auth.
Michael F. Seldin,
Russell Shigeta,
K. Laiho,
Hongzhe Li,
H. Säilä,
A. Savolainen,
M. Leirisalo-Repo,
Kimmo Aho,
E. Tuomilehto-Wolf,
K. Kaarela,
...
M. Kauppi,
H. Alexander,
A. Begovich,
J. Tuomilehto
|
6 |
2005 |
6 🐜
|
🐜
|
Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis
9 auth.
J. Albers,
L. Paimela,
P. Kurki,
K. Eberhardt,
P. Emery,
M. A. V. '. Hof,
...
F.H.J.M. Schreuder,
M. Leirisalo-Repo,
P. V. Riel
|
6 |
2001 |
6 🐜
|
🐢
|
Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients’ sickness absence and gross income: experience from the FIN-RACo trial
10 auth.
K. Puolakka,
Hannu Kautiainen,
Markku Pekurinen,
T. Möttönen,
P. Hannonen,
M. Korpela,
...
M. Hakala,
M. Arkela-Kautiainen,
R. Luukkainen,
M. Leirisalo-Repo
|
6 |
2005 |
6 🐢
|
🐬
|
Reactive arthritis following an outbreak of Salmonella Bovismorbificans infection.
L. Mattila,
M. Leirisalo-Repo,
P. Pelkonen,
S. Koskimies,
K. Granfors,
Anja Siitonen
|
6 |
1998 |
6 🐬
|
🐜
|
Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold.
14 auth.
Henning Zeidler,
T. Kvien,
P. Hannonen,
F. Wollheim,
Øystein Førre,
H. Geidel,
I. Hafström,
J. Kaltwasser,
M. Leirisalo-Repo,
B. Manger,
...
L. Laasonen,
E. Markert,
H. Prestele,
P. Kurki
|
6 |
1998 |
6 🐜
|
🐢
|
Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis.
L. Paimela,
Arja Heiskanen,
P. Kurki,
T. Helve,
M. Leirisalo-Repo
|
6 |
1991 |
6 🐢
|